Tadalafil Tablet 100mg (Tadalafil tablets) is a prescription drug used to treat male erectile dysfunction (ED). It inhibits the PDE5 enzyme, reduces the degradation of cyclic guanosine monophosphate (cGMP), enhances nitric oxide (NO) - mediated vascular smooth muscle relaxation, increases penile corpus cavernosum blood flow, and helps men maintain erections under sexual stimulation. It needs to work under sexual stimulation, and the drug does not work without sexual stimulation. However, it is contraindicated for patients taking nitrate ester drugs (such as nitroglycerin) as they may cause fatal hypotension, as well as for those allergic to tadalafil or excipients, and for patients with genetic galactose intolerance, lactase deficiency, or glucose galactose malabsorption.
Our products
 |
 |
 |
 |
 |
Additional information of chemical compound:
|
|
|
Tadalafil COA
Tadalafil Tablet 100mg is an oral phosphodiesterase type 5 (PDE5) inhibitor with the molecular formula C ₂₂ H ₁₉ N ∝ O ₄ and a molecular weight of 389.41. Its chemical name is (6R, 12aR) -6- (1,3-benzodioxolan-5-yl) -2-methyl-2,3,6,7,12,12-hexahydropyrazino [1 ', 2': 1,6] pyrido [3,4-b] indole-1,4-dione. As a PDE5 inhibitor, Tadalafil enhances the vascular smooth muscle relaxation effect mediated by nitric oxide (NO) by inhibiting PDE5 enzyme activity and reducing the degradation of cyclic guanosine monophosphate (cGMP). In the corpus cavernosum of the penis, this mechanism can increase blood flow and help men maintain erection under sexual stimulation; In pulmonary arteries, it can reduce pulmonary vascular resistance and improve the exercise capacity of patients with pulmonary arterial hypertension (PAH).
The manufacturing background and controversy of 100mg dosage form
Conventional dose range
The conventional therapeutic doses of Tadalafil are 2.5mg, 5mg, 10mg, and 20mg, with 20mg being the maximum recommended dose for treating erectile dysfunction (ED). The 100mg dosage form is not a standard specification and its existence may be due to the following background:
Special research needs: Some clinical trials may explore the pharmacokinetics or efficacy of high-dose Tadalafil, but such studies must strictly follow ethical standards and be conducted under the supervision of professional institutions.
Non formal channel products: There may be unapproved 100mg dosage forms on the market, and their manufacturing process may lack quality control, resulting in risks such as inaccurate dosage and excessive impurities.
Risk of excessive dosage
Safety issues: The conventional dose of Tadalafil is sufficient to meet the needs of most ED patients, and a dose of 100mg may significantly increase the incidence of adverse reactions, including common side effects such as headache, facial flushing, indigestion, muscle pain, as well as serious adverse reactions such as visual abnormalities, hearing loss, and abnormal erections of the penis (lasting for more than 4 hours).
Drug interaction risk: High dose Tadalafil combined with nitrate ester drugs (such as nitroglycerin) may cause fatal hypotension; Combined use with CYP3A4 inhibitors (such as ketoconazole) may further increase blood drug concentrations and exacerbate toxicity.
Key points of manufacturing process and quality control
Although the 100mg dosage form is not a standard specification, its manufacturing process still needs to comply with Good Manufacturing Practice (GMP). The following are the manufacturing process and quality control points for conventional Tadalafil tablets:
Raw material processing
Crushing and screening: Grind the Tadalafil raw material to the appropriate particle size, and ensure uniform particle size distribution through screening to improve mixing uniformity.
Drying and sterilization: Dry the raw materials to remove moisture and prevent clumping; If necessary, sterilization treatment should be carried out to ensure that the microbial limit meets the requirements.
Preparation of formulations
Wet granulation: Mix Tadalafil with excipients (such as microcrystalline cellulose, lactose, cross-linked polyvinylpyrrolidone, etc.), add adhesive (such as polyvinylpyrrolidone K30 solution) for granulation, and improve particle flowability and compressibility through wet granulation.
Drying and granulation: Dry wet particles to the appropriate moisture content, crush large particles through a granulator to ensure uniform particle size.
Tablet pressing: Mix the dried particles with a lubricant (such as magnesium stearate) and press them into tablets. During the compression process, it is necessary to control indicators such as tablet weight difference, hardness, and brittleness.
Coating process
Film coating: Water soluble film coating materials (such as hydroxypropyl methylcellulose) are used to coat tablets, improve their appearance, mask unpleasant odors, and control drug release rate.
Coating parameter control: During the coating process, it is necessary to control parameters such as spray speed, inlet air temperature, and exhaust air temperature to ensure coating uniformity.
quality control
Content determination: High performance liquid chromatography (HPLC) is used to determine the content of Tadalafil in tablets, ensuring that the content meets the requirements of the labeled amount.
Dissolution test: Simulate the in vivo environment, measure the dissolution of tablets in a specified medium, and ensure that the drug release behavior meets the requirements.
Microbial limit test: Conduct microbial limit tests on tablets to ensure sterility or microbiological content meets pharmacopoeia standards.
Stability study: By conducting long-term stability tests and accelerated stability tests, the quality changes of tablets under different conditions are examined to determine the expiration date.
Manufacturing considerations for special dosage forms (such as 100mg)
To manufacture Tadalafil Tablet 100mg dosage form, the following adjustments and considerations need to be made on the basis of conventional processes:
Dose accuracy
Raw material weighing: Tadalafil raw material is weighed using a high-precision balance to ensure accurate dosage.
Mixing uniformity: Due to the large dosage, it is necessary to strengthen the control of the mixing process to ensure that the raw materials and excipients are mixed evenly and avoid dosage deviation.
Optimization of tablet pressing process
Tablet weight control: 100mg tablets have a relatively large tablet weight, and the tablet pressing process needs to be optimized to ensure that the difference in tablet weight meets the requirements.
Hardness and Fragility: High dose tablets may face problems such as insufficient hardness and excessive fragility, which need to be optimized by adjusting parameters such as compression pressure and lubricant dosage.
Selection of Coating Materials
Coating thickness: The coating thickness of high-dose tablets may increase, and suitable coating materials and processes need to be selected to ensure coating uniformity.
Drug release: To control the drug release rate, it is necessary to choose sustained-release or controlled release coating materials and optimize the coating process parameters.
safety assessment
Preclinical studies: Prior to manufacturing the 100mg dosage form, sufficient preclinical studies are required to evaluate its safety and efficacy.
Clinical trials: If the 100mg dosage form is planned for clinical use, rigorous clinical trials are required to verify its efficacy and safety.
Compliance and ethical considerations
Regulatory compliance
Drug registration: To manufacture 100mg dosage forms, a registration application must be submitted to the drug regulatory department, providing sufficient research data to support its safety and efficacy.
GMP certification: The manufacturing process must comply with GMP requirements to ensure controllable drug quality.
Ethical considerations
Patient safety: High doses of Tadalafil may increase patient risk, and the decision to use it should be made after fully evaluating the patient's benefits and risks.
Doctor's guidance: The 100mg dosage form should only be used under strict guidance from a doctor, and patients are not allowed to adjust the dosage on their own.
adverse reaction
Tadalafil Tablet 100mg, as the active pharmaceutical ingredient (API) of phosphodiesterase 5 (PDE5) inhibitor drugs, not only brings significant therapeutic effects, but also inevitably accompanies a series of physiological reactions, namely adverse reactions (ADRs). Unlike standardized drugs, the direct use of raw material powders greatly amplifies these risks.
Identification and treatment of serious adverse reactions
Tadalafil may cause serious cardiovascular adverse reactions, including chest pain, angina, myocardial infarction, and arrhythmia, especially for patients with a history of cardiovascular disease, the risk is higher. The mechanism of its occurrence is related to drug vasodilation leading to increased myocardial oxygen consumption and insufficient coronary artery blood supply. Management strategies include:
- Stop medication immediately: If symptoms such as chest pain, palpitations, or difficulty breathing occur, stop medication immediately and seek medical attention.
- Electrocardiogram monitoring: Conduct an electrocardiogram examination to assess the presence of myocardial ischemia or arrhythmia.
- Cardiovascular assessment: For patients with a history of cardiovascular disease, a comprehensive cardiovascular assessment, including exercise stress testing or coronary angiography, should be performed before use.
- Contraindications: It is contraindicated for patients who have recently experienced myocardial infarction, unstable angina, refractory arrhythmia, hypotension, or refractory hypertension.
Tadalafil may cause serious visual system adverse reactions, including blurred vision, color vision abnormalities, and non arterial anterior ischemic optic neuropathy (NAION), which may lead to permanent vision loss. The mechanism of its occurrence is related to drug dilation of retinal blood vessels leading to retinal ischemia. Management strategies include:
- Immediate discontinuation of medication: When symptoms such as blurred vision or abnormal color vision occur, medication should be stopped immediately and medical attention should be sought.
- Ophthalmic evaluation: Conduct fundus examination and visual field testing to assess the presence of retinal ischemia or NAION.
- Contraindications: Patients with a history of NAION or hereditary retinal lesions (such as retinitis pigmentosa) are contraindicated.
Tadalafil may cause serious auditory system adverse reactions, including sudden hearing loss and tinnitus. The mechanism of its occurrence is not yet clear, but it may be related to insufficient blood supply caused by inner ear vascular spasm. Management strategies include:
- Stop medication immediately: When symptoms such as hearing loss or tinnitus occur, stop medication immediately and seek medical attention.
- Listening test: Conduct pure tone audiometry and acoustic impedance testing to assess the degree of hearing loss.
- Avoid noise exposure: Reduce noise exposure and avoid the use of ototoxic drugs (such as aminoglycoside antibiotics).
Hot Tags: tadalafil tablet 100mg, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale